News and Inspirational Stories
New Report: ACS Cancer Facts & Figures 2024 report five-year relative survival rate for pancreatic cancer increased to 13%
FEATURED Articles
Discoveries
Cold Spring Harbor Laboratory (CSHL) is at the forefront of using organoid technology to study and treat cancer. Organoids are tiny 3D clusters of cells that are miniature versions of patients’ tumors.
The annual American Society of Clinical Oncology (ASCO) meeting brings together scientists from across the country who are studying every type of cancer to share the latest results from the […]
With a five-year survival rate of only 11%, pancreatic cancer patients need more effective therapies. A new form of immunotherapy is showing promise, as it shrank metastases and stopped progression […]
Neoadjuvant gemcitabine-based chemoradiotherapy prolonged OS compared with upfront surgery among patients with resectable and borderline resectable pancreatic cancer, according to phase 3 study results in Journal of Clinical Oncology.
Real Talk: Survivor, Patient & Family Stories
Michael, Jared, and Lily Leff Cindy and Michael Leff lived the love story most people only dream of. Together since they were just 14, the high school sweethearts from Long […]
Geoff Shudtz was diagnosed with Stage IV pancreatic cancer in December 2017, when he was 34, and his son, Emerson, was just three weeks old. At the time, no oncologist […]
Charul Kothari Charul remembers her mom, Pushpa, as energetic, empathetic, and very progressive for her time, one of very few women in her community in India to have a master’s […]
Bill Garnet Bill Garnet and his beloved wife, Jacque Lueth, would have marked their 35th wedding anniversary last November—ironically, during Pancreatic Cancer Awareness Month. Instead of celebrating this milestone together, […]
Early Detection
Newswise — A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining […]
The incidental identification of pancreatic cysts has become more common with the increasing use of imaging modalities in clinical practice. Currently, an estimated 15% of Americans are believed to harbor […]
A test that spots pancreatic cancer from a single drop of blood could improve survival rates. The first blood test for early diagnosis of the hard-to-spot disease, it could be […]
Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer. Findings from the new study suggest that […]
Therapeutics
LUSTGARTEN FUNDED RESEARCH: An adjuvant treatment regimen that included autogene cevumeran, an investigational individualized neoantigen-specific mRNA vaccine, induced durable and functional T-cell responses that were associated with a reduced risk […]
LUSTGARTEN FUNDED RESEARCH: A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig […]
LUSTGARTEN FUNDED RESEARCH: Researchers at the University of Toronto’s Donnelly Centre for Cellular and Biomolecular Research have found two enzymes that work against the chemotherapy drug gemcitabine, preventing it from effectively treating […]
Preliminary analysis of data from an ongoing investigator-initiated, single-center Phase 1 study supported by BioNTech and Genentech and conducted at Memorial Sloan Kettering Cancer Center, New York, United States. Autogene […]
Precision Medicine
A molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, multi-center study led by University of Pittsburgh School of Medicine and UPMC researchers.
Noxopharm Ltd (ASX:NOX) has delivered encouraging preclinical data from its novel ‘dual-cell’ therapy drug that attacks pancreatic cancer in a different and innovative way.
With a five-year survival rate of only 11%, pancreatic cancer patients need more effective therapies. A new form of immunotherapy is showing promise, as it shrank metastases and stopped progression […]
Researchers have managed to tame pancreatic cancer in a woman whose cancer was far advanced and after other forms of treatment had failed.
The Researchers
UNIONDALE, NY, Aug 15, 2024 — The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a landmark year of funding, awarding ten new grants to […]
CAI grants awarded to Eric Christenson, MD, & Andrew Lowy, MD WOODBURY, N.Y., July 30, 2024 — The Lustgarten Foundation has announced two new Dr. Robert F. Vizza Lustgarten Clinical […]
Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, Awarded 2024 LEAD Project Grant WOODBURY, N.Y., May 30, 2024 — The Lustgarten Foundation has announced that the 2024 […]
Linda Resar, MD, Professor of Medicine, Oncology, and Pathology, Johns Hopkins University, Awarded 2024 Innovation and Collaboration Program Grant WOODBURY, N.Y., May 27, 2024 — The Lustgarten Foundation announced today […]